Jeff Yass’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Jeff Yass’s Portfolio OCAT Stock Details OCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-78,364	Closed	-$659K	–	10308
2015 Q4	$659K	Buy	78,364 +19,933	+34%	+$133K	﹤0.01%	6260
2015 Q3	$244K	Buy	58,431 +20,387	+54%	+$89K	﹤0.01%	8392
2015 Q2	$200K	Sell	38,044 -22,999	-38%	-$147K	﹤0.01%	9294
2015 Q1	$376K	Buy	+61,043	New	+$391K	﹤0.01%	7605

Jeff Yass's OCAT Position: Q1 2016 in Review

Jeff Yass sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 78,364 shares — an estimated $659K sold.

Jeff Yass first reported a position in OCAT in Q1 2015 and held it in 4 quarters. The position peaked at $659K in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

Jeff Yass reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
Jeff Yass sold 78,364 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $659K.
Jeff Yass first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q1 2015 and held it in 4 quarters.
Jeff Yass's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $659K in Q4 2015.
1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Susquehanna International Group's 13F filing for Q1 2016, filed 13 May 2016.